124 related articles for article (PubMed ID: 2334571)
1. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981.
Larson B; Silfverswärd C; Nilsson B; Pettersson F
Acta Oncol; 1990; 29(2):185-91. PubMed ID: 2334571
[TBL] [Abstract][Full Text] [Related]
2. Leiomyosarcoma of the uterus.
Van Dinh T; Woodruff JD
Am J Obstet Gynecol; 1982 Dec; 144(7):817-23. PubMed ID: 7148905
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
[TBL] [Abstract][Full Text] [Related]
4. Uterine leiomyosarcoma: an updated series.
Rauh-Hain JA; Oduyebo T; Diver EJ; Guseh SH; George S; Muto MG; del Carmen MG
Int J Gynecol Cancer; 2013 Jul; 23(6):1036-43. PubMed ID: 23714705
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.
Mayerhofer K; Obermair A; Windbichler G; Petru E; Kaider A; Hefler L; Czerwenka K; Leodolter S; Kainz C
Gynecol Oncol; 1999 Aug; 74(2):196-201. PubMed ID: 10419731
[TBL] [Abstract][Full Text] [Related]
6. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
[No Abstract] [Full Text] [Related]
7. Factors Affecting Overall Survival in Premenopausal Women With Uterine Leiomyosarcoma: A Retrospective Analysis With Long-Term Follow-Up.
Singh N; Al-Ruwaisan M; Batra A; Itani D; Ghatage P
J Obstet Gynaecol Can; 2020 Dec; 42(12):1483-1488. PubMed ID: 32900677
[TBL] [Abstract][Full Text] [Related]
8. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcomas of the female genital tract: a clinical and histopathological study.
Friedrich M; Villena-Heinsen C; Mink D; Hell K; Schmidt W
Eur J Gynaecol Oncol; 1998; 19(5):470-5. PubMed ID: 9863915
[TBL] [Abstract][Full Text] [Related]
10. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
11. [Leiomyosarcoma of the uterus--a clinicopathologic analysis of 11 cases].
He WC
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):444-6. PubMed ID: 2076642
[TBL] [Abstract][Full Text] [Related]
12. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
[TBL] [Abstract][Full Text] [Related]
13. Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.
D'Angelo E; Espinosa I; Ali R; Gilks CB; Rijn Mv; Lee CH; Prat J
Gynecol Oncol; 2011 May; 121(2):328-33. PubMed ID: 21316747
[TBL] [Abstract][Full Text] [Related]
14. Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.
Lamm W; Natter C; Schur S; Köstler WJ; Reinthaller A; Krainer M; Grimm C; Horvath R; Amann G; Funovics P; Brodowicz T; Polterauer S
BMC Cancer; 2014 Dec; 14():981. PubMed ID: 25523155
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of the uterus: case reports and a review.
Gallup DG; Cordray DR
Obstet Gynecol Surv; 1979 Apr; 34(4):300-12. PubMed ID: 471365
[TBL] [Abstract][Full Text] [Related]
16. Impact of adjuvant treatment on oncologic outcomes in patients with stage I leiomyosarcoma of the uterus.
Boyraz G; Başaran D; Salman MC; Özgül N; Yüce K
Turk J Med Sci; 2017 Jun; 47(3):841-846. PubMed ID: 28618731
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcoma with myxoid stroma.
Pounder DJ; Iyer PV
Arch Pathol Lab Med; 1985 Aug; 109(8):762-4. PubMed ID: 3839378
[TBL] [Abstract][Full Text] [Related]
18. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
[TBL] [Abstract][Full Text] [Related]
19. Leiomyosarcoma of the uterus. A 50-year review of 42 cases.
Bartsich EG; Bowe ET; Moore JG
Obstet Gynecol; 1968 Jul; 32(1):101-6. PubMed ID: 5742081
[No Abstract] [Full Text] [Related]
20. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital.
Dinh TA; Oliva EA; Fuller AF; Lee H; Goodman A
Gynecol Oncol; 2004 Feb; 92(2):648-52. PubMed ID: 14766261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]